{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:54:16Z","timestamp":1782237256143,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome is a rare monogenic autoimmune disease, which is caused by mutations in the forkhead box protein 3 gene, can affect various systems. The typical clinical manifestations of IPEX are enteropathy, type 1 diabetes mellitus, and skin diseases. However, some atypical phenotypes can easily be misdiagnosed clinically.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 9-year-and-7-month old patient suffered from recurrent wheezing, hematochezia, and eczematous dermatitis at the age of six months, but did not have any manifestations of autoimmune endocrinopathy. The patient was treated with glucocorticoids for more than six years, and he developed bronchiectasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Whole exome sequencing revealed a hemizygous pathogenic mutation c.1010G&gt;A, p. (Arg337Gln) in Forkhead box protein 3 gene (NM_014009.3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was treated with oral mycophenolate mofetil combined with inhaled budesonide formoterol for six months after diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The respiratory symptoms of the patient seemed to be controlled but eczematous dermatitis progressed, which led the patient to give up the treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Early diagnosis and treatment of IPEX are crucial. Lung injury may be a major problem in the later stages of atypical IPEX, and mycophenolate mofetil seems to control the respiratory symptoms, but could induce significant skin side effects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025174","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:18:28Z","timestamp":1616527108000},"page":"e25174","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A delayed diagnosis of atypical immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-4400","authenticated-orcid":false,"given":"Ying","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan"},{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-911X","authenticated-orcid":false,"given":"Hanmin","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ai","sequence":"additional","affiliation":[{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanmin","family":"Xia","sequence":"additional","affiliation":[{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Luo","sequence":"additional","affiliation":[{"name":"West China University Hospital, Sichuan University."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Duan","sequence":"additional","affiliation":[{"name":"Chengdu Women's and Children's Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T Cells: the Many Faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J Clin Immunol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41424-018-0064-x","article-title":"Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a French multicenter retrospective study","volume":"9","author":"Duclaux-Loras","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1172\/JCI11679","article-title":"JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome","volume":"106","author":"Chatila","year":"2000","journal-title":"J Clin Invest"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"564926","DOI":"10.1155\/2014\/564926","article-title":"Clinical case of immune dysregulation, polyendocrinopaty, enteropathy, X-Linked (IPEX) syndrome with severe immune deficiency and late onset of endocrinopathy and enteropathy","volume":"2014","author":"Savova","year":"2014","journal-title":"Case Rep Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fped.2017.00037","article-title":"Humoral immunodeficiency with hypotonia, feeding difficulties, enteropathy, and mild eczema caused by a classical FOXP3 mutation","volume":"5","author":"Tuijnenburg","year":"2017","journal-title":"Front Pediatr"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2018.12.016","article-title":"A Mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells","volume":"50","author":"Van Gool","year":"2019","journal-title":"Immunity"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmii.2015.10.015","article-title":"Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature","volume":"49","author":"Chen","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aller.2015.01.012","article-title":"Analysis of FOXP3 gene in children with allergy and autoimmune diseases","volume":"44","author":"Pacheco-Gonzalez","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","article-title":"Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-Linked (IPEX) syndrome","volume":"9","author":"Gambineri","year":"2018","journal-title":"Front Immunol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.annder.2019.04.026","article-title":"Erythroderma revealing IPEX syndrome","volume":"146","author":"Bachelerie","year":"2019","journal-title":"Ann Dermatol Venereol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"e27619","DOI":"10.1002\/pbc.27619","article-title":"Primary immune regulatory disorders for the pediatric hematologist and oncologist: a case-based review","volume":"66","author":"Chandrakasan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1556\/650.2018.31122","article-title":"Endocrine complications in primary immunodeficiency diseases","volume":"159","author":"Hal\u00e1sz","year":"2018","journal-title":"Orv Hetil"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00467-017-3682-8","article-title":"PLA2R-positive (primary) membranous nephropathy in a child with IPEX syndrome","volume":"32","author":"Chuva","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/ajmg.a.38144","article-title":"Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound","volume":"173","author":"Louie","year":"2017","journal-title":"Am J Med Genet A"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/MPG.0000000000000554","article-title":"Extremely early onset IPEX syndrome caused by a novel small exonic deletion in FOXP3","volume":"63","author":"Smith","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ped.12570","article-title":"Familial IPEX syndrome: different glomerulopathy in two siblings","volume":"57","author":"Park","year":"2015","journal-title":"Pediatr Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"(Suppl 1)","key":"R22-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10875-016-0294-1","article-title":"Autoimmunity and primary immunodeficiency disorders","volume":"36","author":"Allenspach","year":"2016","journal-title":"J Clin Immunol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood-2009-05-219584","article-title":"Epigenetic mechanisms of regulation of Foxp3 expression","volume":"114","author":"Lal","year":"2009","journal-title":"Blood"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.it.2014.06.005","article-title":"Post-translational modification networks regulating FOXP3 function","volume":"35","author":"van Loosdregt","year":"2014","journal-title":"Trends Immunol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13052-014-0068-4","article-title":"Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea","volume":"40","author":"Zama","year":"2014","journal-title":"Ital J Pediatr"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12016-016-8591-2","article-title":"An update on the use of immunomodulators in primary immunodeficiencies","volume":"52","author":"Vignesh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.clinre.2015.03.006","article-title":"Long-term disease course in a patient with severe neonatal IPEX syndrome","volume":"39","author":"Duclaux-Loras","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2019.11.043","article-title":"Treatment with rapamycin can restore regulatory T-cell function in IPEX patients","volume":"145","author":"Passerini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","article-title":"Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study","volume":"141","author":"Barzaghi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clim.2018.03.008","article-title":"IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective TReg cell engraftment","volume":"191","author":"Magg","year":"2018","journal-title":"Clin Immunol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/jmedgenet-2012-100759","article-title":"The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome","volume":"49","author":"d\u2019Hennezel","year":"2012","journal-title":"J Med Genet"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpeds.2017.03.051","article-title":"Persistent enteropathy in a toddler with a novel FOXP3 mutation and normal FOXP3 protein expression","volume":"186","author":"Seghezzo","year":"2017","journal-title":"J Pediatr"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clim.2018.10.005","article-title":"Hypogammaglobulinemia with decreased class-switched B-cells and dysregulated T-follicular-helper cells in IPEX syndrome","volume":"197","author":"Shamriz","year":"2018","journal-title":"Clin Immunol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/imcb.12209","article-title":"Hyper IgE syndromes: clinical and molecular characteristics","volume":"97","author":"Al-Shaikhly","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clim.2019.03.011","article-title":"Identification of autoantibodies using human proteome microarrays in patients with IPEX syndrome","volume":"203","author":"Hoshino","year":"2019","journal-title":"Clin Immunol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/imr.12717","article-title":"Zero tolerance! A perspective on monogenic disorders with defective regulatory T cells and IBD-like disease","volume":"287","author":"Abdel-Motal","year":"2019","journal-title":"Immunol Rev"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fimmu.2015.00185","article-title":"Early-onset autoimmune disease as a manifestation of primary immunodeficiency","volume":"6","author":"Carneiro-Sampaio","year":"2015","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:27:31Z","timestamp":1746340051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025174"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025174","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"2020-12-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}